P281424/AMR
1
0
Fork 0
mirror of https://github.com/msberends/AMR.git synced 2026-05-31 13:41:42 +02:00
Code Releases Activity

Built site for AMR@3.0.1.9055: f7e9294

Browse Source
This commit is contained in:
github-actions
2026-04-30 17:52:11 +00:00
parent 3a3027f171
commit 6fbd9e4b9f
89 changed files with 553 additions and 154 deletions
Download Patch File Download Diff File Expand all files Collapse all files

20
articles/AMR.md
View File

@@ -805,16 +805,16 @@ example_isolates %>%
wisca(antibiotics = c("TZP", "TZP+TOB", "TZP+GEN"))
```
| age_group | gender | Piperacillin/tazobactam | Piperacillin/tazobactam + Gentamicin | Piperacillin/tazobactam + Tobramycin |
|:---|:---|:---|:---|:---|
| 0-24 | F | 56.6% (25.2-83.9%) | 73.6% (48-91.6%) | 68.6% (42.9-89.5%) |
| 0-24 | M | 60.3% (28.4-87.1%) | 79.7% (57.6-94.2%) | 60.1% (29.5-87.7%) |
| 25-49 | F | 66.6% (45.6-85.5%) | 91.7% (84.6-96.7%) | 83% (67.9-94%) |
| 25-49 | M | 56.4% (29.1-81.7%) | 89.2% (80.3-95.7%) | 72.4% (49.7-90%) |
| 50-74 | F | 67.8% (55.8-80.1%) | 95.6% (93.2-97.5%) | 88.1% (80.4-94.6%) |
| 50-74 | M | 66.2% (54.8-75.8%) | 95.2% (92.4-97.4%) | 84.4% (74.4-92.5%) |
| 75+ | F | 71.7% (61-81.7%) | 96.6% (94.4-98.2%) | 90.6% (84.6-95.3%) |
| 75+ | M | 72.9% (63.8-82%) | 96.6% (94.6-98.1%) | 92.8% (87.8-96.5%) |
| age_group | gender | Amikacin | Amoxicillin | Amoxicillin/clavulanic acid | Ampicillin | Azithromycin | Benzylpenicillin | Cefazolin | Cefepime | Cefotaxime | Cefoxitin | Ceftazidime | Ceftriaxone | Cefuroxime | Chloramphenicol | Ciprofloxacin | Clindamycin | Colistin | Doxycycline | Erythromycin | Flucloxacillin | Fosfomycin | Gentamicin | Imipenem | Kanamycin | Linezolid | Meropenem | Metronidazole | Moxifloxacin | Mupirocin | Nitrofurantoin | Oxacillin | Piperacillin/tazobactam | Rifampicin | Teicoplanin | Tetracycline | Tigecycline | Tobramycin | Trimethoprim | Trimethoprim/sulfamethoxazole | Vancomycin |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| 0-24 | F | 45.4% (15.4-79%) | 50.1% (20.5-77.6%) | 69% (44.5-88.5%) | 50.4% (20.6-77.3%) | 41.9% (18.1-65.6%) | 36.1% (12.3-64.3%) | NA | NA | 63.9% (34.6-87.6%) | 56.7% (25.9-85.8%) | 51.5% (25.6-74.4%) | 63.4% (32-88.1%) | 70.4% (45.4-89.1%) | 54% (22.3-85.3%) | 69.8% (45.9-88.9%) | 39.3% (17.7-64.6%) | 45.3% (18.1-75.9%) | 50.1% (21.5-80.5%) | 41.7% (19.1-67.6%) | 55.8% (23.7-83.3%) | 63.5% (32.6-89.4%) | 69.3% (44.6-88.3%) | 63.6% (36.1-88.2%) | 45.5% (15.7-77.7%) | 43.3% (17.8-71.2%) | 55.9% (24.3-82.2%) | NA | NA | 56.5% (24.3-85%) | 56.8% (30.9-82.3%) | 50.5% (19.4-80.8%) | 56.9% (26.7-85%) | 42.3% (18.3-68.8%) | 40.2% (17.6-67.7%) | 49.8% (20-79.3%) | 56.1% (22-85.4%) | 64.5% (39.6-85.5%) | 69.7% (42.3-90.4%) | 75.4% (52.1-91.7%) | 48.5% (24.3-72.6%) |
| 0-24 | M | 41.9% (15.2-72.5%) | 49.4% (23.3-75.5%) | 73.8% (51.8-90.1%) | 49.3% (22.7-76%) | 63.4% (40.7-83.5%) | 41.8% (20.4-64.8%) | 56.8% (25.2-83.5%) | 58.2% (29.1-85.8%) | 59.7% (29.1-87.4%) | 59.3% (29.1-86.6%) | 24.9% (8.9-47.3%) | 58.5% (28-86.5%) | 72.1% (47.9-90.5%) | NA | 77.2% (53-93.2%) | 61.6% (36.2-83.6%) | 25.5% (8.7-46.1%) | 69.4% (44.6-89.4%) | 63.4% (41.8-82.7%) | 64% (37.6-85.6%) | NA | 63.5% (40.9-83.1%) | 58.7% (27.6-86.5%) | 41.8% (13.6-71.2%) | 48.3% (17.9-78%) | 59.2% (27.4-86.4%) | NA | NA | NA | 53% (21.3-83.7%) | 57.2% (24.6-84.6%) | 59.9% (29.7-85.6%) | 48.2% (16.1-80.4%) | 48.4% (17.4-79.8%) | 68% (43.5-87.3%) | 65.7% (36-89.2%) | 44.3% (17.2-73.4%) | 69.4% (46.9-87.8%) | 74% (50.8-90.9%) | 75.3% (52.4-92.2%) |
| 25-49 | F | 46.8% (26.7-65.6%) | 39% (26.3-52.9%) | 73.8% (63.5-82.6%) | 39.3% (27.2-54.4%) | 54.8% (44.9-64.8%) | 36.5% (26.3-47.1%) | 66.4% (46.1-85%) | 69.2% (49.1-86.2%) | 70.2% (50.5-86.2%) | 68.1% (48.6-85.4%) | 27.9% (19.2-37.9%) | 70.1% (50.5-87.1%) | 71.4% (61.7-80.4%) | 58.2% (35.3-79.9%) | 85.5% (74.1-94.2%) | 67.1% (55.8-77.4%) | 25.8% (17-36%) | 75.5% (61.2-88.2%) | 54.9% (44.8-65.6%) | 55.2% (37.8-72.5%) | 60.9% (38.3-81.8%) | 75.2% (65.7-83.5%) | 69.9% (50.1-86.6%) | 37.5% (17.7-57.9%) | 50.7% (30.8-68.7%) | 69.4% (48.6-86.7%) | NA | 56.9% (36.2-77.7%) | 53.3% (30.9-75.6%) | 60.1% (38.1-81.8%) | 64.3% (43.2-83.6%) | 66% (45.7-85.2%) | 50.1% (30-69.6%) | 38.8% (19.6-58.9%) | 75.8% (61.6-88.1%) | 73.3% (56.6-89.5%) | 62.7% (47.6-77.1%) | 70.4% (58.7-80.2%) | 90% (82.9-95.4%) | 71.6% (61.7-80.4%) |
| 25-49 | M | 49.8% (24.2-75.8%) | 16.5% (8.1-27.4%) | 72.4% (60.5-83.5%) | 16.6% (7.7-28.2%) | 55.9% (43.6-67.9%) | 24.9% (14.7-37.6%) | 60.3% (33.2-82.4%) | 55.3% (27.6-81.8%) | 55.9% (29.7-81.1%) | 56.2% (27.7-82.1%) | 22.2% (12.7-33.9%) | 55.6% (29.1-81.8%) | 73.7% (62.6-83.8%) | 52.9% (25.2-79.6%) | 67.1% (53-79.8%) | 57.8% (43.5-71.8%) | 22.3% (12.6-33.6%) | 73% (57.8-85.5%) | 55.8% (43-68.2%) | 66.5% (51.6-79.4%) | 63.1% (40.3-84.5%) | 83.9% (74.5-91.7%) | 56.4% (28.4-84%) | 45.4% (18.9-73.8%) | 59.4% (37.6-77.9%) | 56.3% (28.8-81.1%) | NA | 52.8% (24.7-78.7%) | 64.2% (40.2-84.5%) | 62.9% (37.7-85.1%) | 60.5% (37.1-80.7%) | 55.8% (29.4-82.9%) | 65.4% (48.7-80.8%) | 54.5% (31.7-73.7%) | 72.8% (58.7-84.8%) | 84.8% (72.4-93.6%) | 66.7% (44.5-84.1%) | 71.4% (58.9-82.6%) | 86.6% (77.9-93.7%) | 77.1% (65.5-87.1%) |
| 50-74 | F | 44.8% (35.8-54.1%) | 30.1% (24.9-35.3%) | 74.1% (69.2-78.7%) | 30% (24.6-35.4%) | 41.9% (36.5-47.3%) | 23.5% (18.6-29%) | 73.1% (62-82.9%) | 76.6% (66.1-86%) | 74.8% (64.9-84.5%) | 74.6% (64.2-83.3%) | 37.5% (32.3-43.4%) | 74.8% (64.4-83.8%) | 74.5% (69.7-78.9%) | 61.2% (40.3-82.4%) | 79.4% (73-85%) | 44.9% (38.7-51%) | 37.8% (32.7-43.3%) | 63.8% (47.6-80.1%) | 41.7% (36.6-46.9%) | 58.1% (40-75.1%) | 65.2% (53.5-76.6%) | 78.7% (73.8-83.2%) | 80.6% (70.3-90%) | 28.1% (10.1-46.6%) | 53.2% (42.9-62.4%) | 79.3% (68.7-88.6%) | NA | 49.5% (37.5-61.8%) | 67.8% (48.5-86%) | 75.1% (63.3-86.3%) | 56.6% (37.8-74.2%) | 67.7% (56.4-79.6%) | 50.6% (40.9-59.1%) | 41.3% (31.5-50.4%) | 59% (48.3-74.5%) | 87.7% (80.4-94.1%) | 62.2% (55.4-68.4%) | 55.5% (49.8-61.1%) | 68% (62.7-73.3%) | 60.9% (55.8-66.1%) |
| 50-74 | M | 38.8% (30.6-48.6%) | 34.6% (29.1-40.3%) | 75% (70-79.5%) | 34.7% (29.2-40.5%) | 43.4% (37.8-48.5%) | 21% (16.5-26.4%) | 64.3% (54.1-74.1%) | 65.9% (56.5-75.4%) | 67.3% (58.3-77%) | 65.9% (56.1-75.9%) | 32.9% (27.6-38%) | 67.3% (57.4-76.8%) | 74.1% (69.2-78.8%) | 63.5% (42.4-83%) | 76.9% (71.6-81.9%) | 47.3% (40.9-53.8%) | 30.8% (26.1-36.1%) | 68.5% (53.5-81.9%) | 43.4% (37.7-48.8%) | 58.1% (42.4-73.2%) | 68.1% (53.5-82.2%) | 79.1% (74.4-83.1%) | 69% (59.7-78.3%) | 24.8% (9.5-40.5%) | 49.7% (35-63.2%) | 68.1% (58.1-77.6%) | 53.8% (32-75%) | 51.7% (36.1-67.3%) | 68.8% (51.1-85.7%) | 70.2% (54.7-85.3%) | 53.2% (37.5-68.7%) | 66.5% (55-76.8%) | 56.2% (45.8-65.4%) | 44% (30.3-57.5%) | 71.9% (58.2-82.2%) | 86.8% (77.3-93.6%) | 54.1% (46.9-61.4%) | 67.1% (61.5-72.5%) | 81% (76.4-85.2%) | 66.3% (61-71.2%) |
| 75+ | F | 51.4% (41.7-62%) | 30.9% (26.2-36.5%) | 74.4% (70.3-78.6%) | 30.9% (25.7-36.1%) | 36.6% (32-41.6%) | 20.7% (16.2-25.4%) | 73.6% (63.6-82.5%) | 79.1% (70.6-86.8%) | 78.6% (69.9-86.3%) | 76% (67.5-83.7%) | 43.1% (38.6-48%) | 78.9% (70.5-86.4%) | 77% (72.6-81.3%) | 63.2% (43.2-84.1%) | 77.7% (72.1-83.2%) | 41.2% (36-46.4%) | 39.1% (34.2-44.4%) | 63.7% (46.3-80.6%) | 36.5% (31.9-41.2%) | 57.1% (39.8-76%) | 65.8% (57.2-73.5%) | 84.6% (80.6-88%) | 81.9% (73.7-89.5%) | 33.3% (13.7-53%) | 49.6% (42.3-56.1%) | 81.3% (73.2-88.9%) | 55.9% (33.5-76.5%) | 41% (31.4-51.8%) | 63.7% (43.8-82.3%) | 77.8% (66-87.4%) | 56.3% (37.3-75.1%) | 71.8% (62-82.2%) | 48.3% (41.5-54.9%) | 43.3% (36.2-50.7%) | 63% (45.3-80.3%) | 85.9% (79.9-90.9%) | 70.4% (64.1-76.8%) | 60.4% (55.1-65.8%) | 77.6% (73.4-82.1%) | 55.3% (50.4-60.1%) |
| 75+ | M | 52.6% (43.3-62.6%) | 33% (28.1-38%) | 77.4% (73.3-81.5%) | 33% (28.2-38.2%) | 36.8% (32.3-41.8%) | 17.9% (12.6-23.2%) | 64.4% (55.4-73.3%) | 71.2% (63.1-79.1%) | 67.9% (59.5-75.8%) | 65.3% (56.3-73.6%) | 42.6% (37.8-47.4%) | 68.2% (59.7-76.4%) | 75.1% (70.9-79.2%) | 64.1% (45.8-81.8%) | 77.6% (72-82.6%) | 41% (36-46.4%) | 39.9% (35.1-44.5%) | 62.1% (46-78.8%) | 36.9% (32.4-41.4%) | 59.7% (43.4-76.6%) | 64.7% (56.6-73.6%) | 83% (79.4-86.7%) | 75.7% (66.6-83%) | 31.6% (12.1-51.7%) | 51.8% (44.9-58%) | 74.2% (65.8-82.7%) | NA | 52.2% (41.5-60.8%) | 69.3% (50.5-86.4%) | 72.2% (58.7-83.4%) | 59.3% (41.6-76.7%) | 73.1% (64.3-81.4%) | 49.9% (42.4-56.9%) | 46.3% (38.2-53.1%) | 59.7% (44.2-75.7%) | 86.8% (81.4-91.3%) | 72% (66.3-77.6%) | 55.8% (50.3-61.1%) | 73.3% (68.9-77.6%) | 57% (52.2-61.6%) |
#### Plotting antibiograms